- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2013
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SGLT2 and cancer ; volume:472 ; number:9 ; day:20 ; month:8 ; year:2020 ; pages:1407-1414 ; date:9.2020
Pflügers Archiv ; 472, Heft 9 (20.8.2020), 1407-1414, 9.2020
- Creator
-
Wright, Ernest M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00424-020-02448-4
- URN
-
urn:nbn:de:101:1-2020102121570214655118
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wright, Ernest M.
- SpringerLink (Online service)
Other Objects (12)
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
SGLT2-inhibitors; more than just glycosuria and diuresis
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
The relationship between SGLT2 and systemic blood pressure regulation
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
SGLT2-inhibitors; more than just glycosuria and diuresis
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
The relationship between SGLT2 and systemic blood pressure regulation
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
SGLT2-inhibitors; more than just glycosuria and diuresis
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
The relationship between SGLT2 and systemic blood pressure regulation
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives